These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 26407354)

  • 21. Comments on 'Comparative effectiveness research: Policy context, methods development and research infrastructure'.
    Morton SC
    Stat Med; 2010 Aug; 29(19):1989-90; discussion 1996-7. PubMed ID: 20683889
    [No Abstract]   [Full Text] [Related]  

  • 22. American Recovery and Reinvestment Act-comparative effectiveness research infrastructure investments: emerging data resources, tools and publications.
    Segal C; Holve E
    J Comp Eff Res; 2014 Nov; 3(6):647-55. PubMed ID: 25494571
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An evaluation of recent federal spending on comparative effectiveness research: priorities, gaps, and next steps.
    Benner JS; Morrison MR; Karnes EK; Kocot SL; McClellan M
    Health Aff (Millwood); 2010 Oct; 29(10):1768-76. PubMed ID: 20921474
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prioritizing Pediatric Surgical Conditions-A Call to Go Beyond Operations, Cost, and Comparative Effectiveness Research.
    Minneci PC; Deans KJ
    JAMA Pediatr; 2017 Feb; 171(2):e163923. PubMed ID: 27942716
    [No Abstract]   [Full Text] [Related]  

  • 25. Expectations for comparative effectiveness and efficacy research: with welcomed questions may come unwelcome answers.
    Eaglstein WH; Kirsner RS
    JAMA Dermatol; 2013 Jan; 149(1):18-9. PubMed ID: 23324750
    [No Abstract]   [Full Text] [Related]  

  • 26. Assessing the value of pediatric consultation services as bundled payments evolve: infectious diseases as a model.
    Castle VP; Gilsdorf JR
    J Pediatr; 2014 Oct; 165(4):650-1.e1. PubMed ID: 25256047
    [No Abstract]   [Full Text] [Related]  

  • 27. Government programs to support pediatric research.
    J Natl Cancer Inst; 2011 Aug; 103(16):1221. PubMed ID: 21813411
    [No Abstract]   [Full Text] [Related]  

  • 28. An Enterovirus D68 Outbreak Highlights the Value of Pediatric Infectious Disease Specialists.
    Schuster JE; Newland JG
    J Pediatric Infect Dis Soc; 2015 Mar; 4(1):87-8. PubMed ID: 26407368
    [No Abstract]   [Full Text] [Related]  

  • 29. Innovative designs of point-of-care comparative effectiveness trials.
    Shih MC; Turakhia M; Lai TL
    Contemp Clin Trials; 2015 Nov; 45(Pt A):61-8. PubMed ID: 26099528
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The historical and moral imperatives of comparative effectiveness research.
    Lauer MS
    Stat Med; 2010 Aug; 29(19):1982-4; discussion 1996-7. PubMed ID: 20683887
    [No Abstract]   [Full Text] [Related]  

  • 31. American Recovery and Reinvestment Act: a stimulus for research.
    Goldberg D
    Penn Dent J (Phila); 2010; ():10-3. PubMed ID: 21941869
    [No Abstract]   [Full Text] [Related]  

  • 32. Making the top-tech list.
    DerGurahian J
    Mod Healthc; 2009 Jul; 39(29):26-8. PubMed ID: 19658234
    [No Abstract]   [Full Text] [Related]  

  • 33. Is treatment heterogeneity an Achilles' heel for comparative effectiveness research?
    Alexander GC; Lambert BL
    Pharmacotherapy; 2012 Jul; 32(7):583-5. PubMed ID: 22760690
    [No Abstract]   [Full Text] [Related]  

  • 34. Cochrane in the United States of America.
    Tovey D; Dellavalle R
    Cochrane Database Syst Rev; 2010 Sep; 2011(9):ED000010. PubMed ID: 21833933
    [No Abstract]   [Full Text] [Related]  

  • 35. The promise and realities of comparative effectiveness research.
    Gatsonis C
    Stat Med; 2010 Aug; 29(19):1977-81; discussion 1996-7. PubMed ID: 20683886
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluating collaborations in comparative effectiveness research: opportunities and challenges for social network analysis.
    Zickafoose JS; Kimmey LD; Tomas A; Esposito D; Rich E
    J Comp Eff Res; 2014 Nov; 3(6):667-75. PubMed ID: 25494573
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The relevance of international studies to informed pharmacoeconomics and health policy decisions.
    Lyles A
    Clin Ther; 2010 Jan; 32(1):106-7. PubMed ID: 20171416
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparative effectiveness questions in oncology.
    Mailankody S; Prasad V
    N Engl J Med; 2014 Apr; 370(16):1478-81. PubMed ID: 24738667
    [No Abstract]   [Full Text] [Related]  

  • 39. Assessing treatment effects in the "real world".
    Jones AS; Shinogle JA
    Clin Ther; 2010 Oct; 32(11):1952-3. PubMed ID: 21095489
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparative effectiveness. An idea whose time has finally come.
    Sipkoff M
    Manag Care; 2009 Apr; 18(4):14-6, 19-21. PubMed ID: 19472562
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.